drugset / Trial / NCT00772551

Raltegravir and Ezetimibe PK Study

NCT00772551

Phase 1 Completed 26 enrolled St Stephens Aids Trust
RandomizedCrossoverOpen-labelTreatment

Summary

Evaluation of the pharmacokinetics and safety of raltegravir and ezetimibe when co-administered to male and female healthy volunteers.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown 10 mg Oral
Comparator Raltegravir Other / unclassified 400 mg Oral